Impact of HAART on liver histology of HIV/HCV coinfected patients

A. De Bona, G. Sitia, C. Uberti-Foppa, L. Galli, D. Ciuffreda, G. Gallotta, C. Paties, A. Lazzarin

Research output: Contribution to journalArticlepeer-review


The impact of HAART on the progression of HCV related liver disease is controversial. This retrospective study compares the grading and staging of chronic viral hepatitis in HIV/HCV coinfected subjects treated or not with antiretroviral therapy (ART) including protease inibithors (PI). The liver histology of 44 HIV/HCV coinfected patients on ART for more than 12 months, 26 coinfected patients naïve for ART and 31 HCV monoinfected patients were analysed by the Ishak score. None of the multivariate models calculated to test if liver histopathology (Ishak grading or staging) between HlV/HCV coinfected patients versus HCV monoinfected or antiretroviral-treated versus untreated HIV+ subjects showed any statistical difference. No significant difference between grading and staging was evidenced either in PI treated subjects versus patients on ART without PI.

Original languageEnglish
Pages (from-to)195-197
Number of pages3
JournalJournal of Biological Regulators and Homeostatic Agents
Issue number2
Publication statusPublished - Apr 2003


  • Chronic hepatitis C
  • Liver histology

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Endocrinology
  • Physiology
  • Immunology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)


Dive into the research topics of 'Impact of HAART on liver histology of HIV/HCV coinfected patients'. Together they form a unique fingerprint.

Cite this